U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06917846) titled 'Medical and Surgical Treatment of MRONJ (Medication-related Osteonecrosis of the Jaw Bones)' on March 31.
Brief Summary: MRONJ is an acronym used to describe medication-related osteonecrosis of the jaw bones. It has been reported by the AAOMS that bisphosphonates or denosumab can cause this condition. The management of medication-related osteonecrosis of the jaw (MRONJ) is challenging, and there is ongoing debate over whether medical or surgical treatment is the gold standard. The aim of this retrospective study is to investigate the efficacies of medical and surgical treatments of MRONJ and comparatively evaluate their outcomes.
...